Table 1.
Serum sample information.
| Male | Female | Average age | Age distribution | |
|---|---|---|---|---|
| Hodgkin’s lymphoma | 9 | 10 | 31.6 | 15–63 |
| NSHL | 3 | 7 | 27.9 | 15–41 |
| MCCHL | 6 | 2 | 37 | 15–63 |
| NLPHL | 0 | 1 | 29 | 29 |
| Non-Hodgkin lymphoma | 152 | 100 | 52.2 | 14–88 |
| B-cell lymphoma | 110 | 77 | 52.6 | 14–88 |
| DLBCL | 73 | 49 | 52 | 14–82 |
| FL | 16 | 13 | 51.7 | 14–80 |
| MALToma | 11 | 8 | 53 | 18–88 |
| MCL | 5 | 3 | 68.4 | 59–77 |
| Burkitt lymphoma | 2 | 0 | 31 | 14–48 |
| Other B-cell lymphoma | 3 | 4 | 54.2 | 17–80 |
| T-cell lymphoma | 18 | 7 | 53.6 | 20–78 |
| AITL | 2 | 1 | 63.3 | 52–78 |
| ALCL | 3 | 1 | 42.8 | 25–61 |
| PTCL | 13 | 5 | 54.3 | 20–75 |
| NK/T-cell lymphoma | 24 | 16 | 49.8 | 28–85 |
| Healthy | 22 | 18 | 41.9 | 19–64 |
DLBCL, diffuse large B cell lymphoma; FL, Follicular lymphoma; MALToma, mucosa-associated lymphoid tissue lymphoma; MCL, Mantle cell lymphoma; AITL, Angioimmunoblastic T cell lymphoma; ALCL, Anaplastic large cell lymphoma; PTCL, Peripheral T cell lymphoma. NSHL, Nodular sclerosing HL; MCCHL, Mixed Cellularity Classical Hodgkin Lymphoma; NLPHL, nodular lymphocyte predominant Hodgkin’s lymphoma.